FDA Aims To “NSURE” Clarity About New Paradigm For OTC Switches
This article was originally published in The Tan Sheet
Executive Summary
FDA official Rikin Mehta assures stakeholders that the proposed new paradigm for Rx-to-OTC switches would not create a third class of drugs, give pharmacists prescribing power or eliminate the need for consumers to visit doctors.